Benefit of Augmented Reality Mirror Therapy in Addition to Conventional Management in Complex Regional Pain Syndrome of the Upper Extremity: a Single Case Experimental Design (SCED) Study.

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Complex Regional Pain Syndrome (CRPS) is a polymorphic joint and periarticular pain syndrome associated with various changes in sensitivity, vasomotor, sudomotor, muscular and trophic changes. The diagnostic criteria of the disease follow the Budapest criteria, namely (i) vasomotor disorders (temperature asymmetry, color changes), (ii) sudomotor/oedema (sweating changes, edema), (iii) sensory (hyperesthesia, allodynia, hyperalgesia) and (iv) motor/trophic (reduced joint mobility, weakness, tremor, dystonia, trophic disorders of skin, nails, hair). Of the many treatments, augmented reality mirror therapy (ARMT), is novel in substituting a virtual environment for part of the real environment. This type of device has never been studied from a clinical point of view in the treatment of upper limb CRPS, whereas fMRI and clinical dissertation studies have suggested an improvement in neuroplasticity. The aim of this study is to establish the clinical effects of ARMT on CRPS, and to evaluate its benefit within a conventional rehabilitation treatment (physiotherapy and occupational therapy).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• The patient must have given their free and informed consent and signed the consent form

• The patient must be a member or beneficiary of a health insurance plan

• Patient with CRPS of the upper limb according to the Budapest criteria.

• Patient newly treated at the Centre d'Evaluation et de Traitement de la Douleur of the CHU of Nîmes.

• Patient with a diagnosis of CRPS for more than 3 months

Locations
Other Locations
France
CHU de Nîmes
RECRUITING
Nîmes
Contact Information
Primary
Arnaud DUPEYRON
arnaud.DUPEYRON@umontpellier.fr
04.66.68.34.59
Time Frame
Start Date: 2023-09-18
Estimated Completion Date: 2025-09
Participants
Target number of participants: 7
Treatments
Experimental: Group 1
2 weeks Conventional therapy / 1 month ARMT / 4 weeks Conventional therapy
Experimental: Group 2
3 weeks Conventional therapy / 1 month ARMT / 3 weeks Conventional therapy
Experimental: Group 3
2.5 weeks Conventional therapy / 1 month ARMT / 3.5 weeks Conventional therapy
Sponsors
Leads: Centre Hospitalier Universitaire de Nīmes

This content was sourced from clinicaltrials.gov